Vela Diagnostics Sequencing System for HIV-1 Genotype Testing
HT9426-26-NOI-5892 · DEPT OF DEFENSE
A IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING solicitation, performed in Silver Spring, MD, with responses due 2026-08-27. AwardCast estimates what this specific solicitation will close for, before you bid.
What's being bought
Notice of Intent (NOI) to Sole Source Title: Vela Sentosa SQ Next Generation Sequencing (NGS) for FDA Approved HIV-1 Genotype Sequencing Requiring Activity: Walter Reed Army Institute of Research (WRAIR) , Diagnostics and Countermeasures Branch (DCB) Related Notice: HT9426-26-RFI-5892 Product Servic
Comparable recent awards in IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
| Winner | Award value | Offers | Date |
|---|---|---|---|
| REMEL INC. | $64K | n/a | 2026-07-02 |
| CEPHEID | $306K | n/a | 2026-07-01 |
| ABBOTT LABORATORIES INC. | $2.8M | n/a | 2026-07-01 |
| BECTON, DICKINSON AND COMPANY | $21K | 1 | 2026-07-01 |
| ABBOTT LABORATORIES INC. | $102K | 1 | 2026-07-01 |
Questions
What is solicitation HT9426-26-NOI-5892?
Vela Diagnostics Sequencing System for HIV-1 Genotype Testing, issued by DEPT OF DEFENSE, under NAICS 325413 (IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING), performed in Silver Spring, MD. Responses are due 2026-08-27.
What do similar contracts close for?
Comparable closed awards in this category ran from $21K to $2.8M, across 5 awards shown above. Those are historical results, not a forecast for this solicitation.
Explore the market
Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.
Every forecast is scored against the real award once it becomes public. See the track record.
Closed awards from public federal data, not the forecast. One email, no account.
Or get the forecast for this solicitation — $49, one report.